North America Internal Neuromodulation Market - Analysis & Forecast to 2019 - New Report Available

From: Fast Market Research, Inc.
Published: Thu Jun 04 2015

North America Internal Neuromodulation Market by Type (Spinal Cord, Deep Brain, Sacral Nerve, Vagus Nerve, Gastric Neuro stimulator), Application (Parkinson's Disease, Chronic pain) - Analysis & Forecast to 2019

The North American neuromodulation market is expected to reach $4,854.4 million by 2019 at a CAGR of 10.5% from 2014 to 2019.

Neuromodulation is defined as the use of technology to regulate the nervous system involving various processes, such as therapeutic alteration, stimulation, modification, inhibition, and others for the proper functioning of the body. This is carried out with the help of implantable devices. These devices are usually neural stimulators, which are used to treat various chronic and acute pain syndromes, dystonia, movement disorders, and spasticity. There are various types of stimulators that are usually used to stimulate the spinal cord and brain. The types include spinal cord stimulator, deep brain stimulator, gastric electrical stimulator, vagus nerve stimulator, and sacral nerve stimulator.

Full Report Details at

The North America neuromodulation market has been segmented by procedure, modality, and geography. On the basis of procedure, the market is further segmented into internal and external stimulation. The internal stimulation segment accounted for a higher market share of 87.4% in the neuromodulation market. The market based on modality covers internal and external modality. The internal modality segment accounted for a higher market share of 85.9%in the neuromodulation market. Further, the market is segmented in terms of geography. Countries, such as the U.S., Canada, and Mexico are included in this market report. The market in the U.S. accounted for the highest share.

The report has profiled the leading players of this market along with the strategies (New product launches, approvals, and acquisitions) adopted by them to sustain and strengthen their position in the North America neuromodulation market. Medtronic Plc. (U.S.), St. Jude Medical (U.S.), Boston Scientific Corp. (U.S.), Cyberonics Inc. (U.S.), Biocontrol Medical (U.S.), and Greatbatch (U.S.) are some of the key players operating in this market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis-industry analysis ,market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the North America neuromodulation market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- North America Pharmacy Information System Market Analysis & Forecast To 2019
- Internal Fixation Devices Market - Global Forecast to 2019
- North America Departmental Picture Archiving and Communication System Market - Analysis and Forecast to 2019
- North America Dental Lasers Market - Analysis and Forecast to 2019
- North America Event Driven Patient Tracking Systems Market - Analysis & Forecast to 2019
Company: Fast Market Research, Inc.
Contact Name: Bill Thompson
Contact Email:
Contact Phone: 1-413-485-7001

Visit website »